Skip to content

Discover ✨Ask Topics Community 🎓Learn

PredictPal is a neutral, third-party aggregator of public prediction-market data. It is informational only — not affiliated with any platform, and it does not facilitate trading or hold funds. Market data is sourced from each platform’s public API and may be delayed.

Sources: Polymarket · Kalshi · Manifold · PredictIt · Hyperliquid · Myriad · Azuro · Limitless · Futuur · ForecastEx · InsightX · XO Market · Smarkets · SX Bet · Metaculus

Compare odds across venues·Resolved markets·How it works·Support·Privacy Policy·Terms of Service

PolymarketTechOpenUpdated 17m ago

FDA approves Viatris' low-dose estrogen weekly patch?

1 markets · 4d

✨ Ask about this event

Markets in this event

Polymarket

Open

FDA approves Viatris' low-dose estrogen weekly patch?

Yes64¢

No37¢

Yes ≈ 64% chance

$4.6K Vol▼ 1pts4d

View on Polymarket ↗

Data from Polymarket’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.

Discussion

optional stance

Loading…

FDA approves Viatris' low-dose estrogen weekly patch? · PredictPal